<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04544618</url>
  </required_header>
  <id_info>
    <org_study_id>HS23957 (H2020:247)</org_study_id>
    <secondary_id>322523 340300 2000</secondary_id>
    <nct_id>NCT04544618</nct_id>
  </id_info>
  <brief_title>Evaluation of a Pre-surgical Virtual Reality Simulation for Breast Cancer Surgery Patients</brief_title>
  <official_title>Preoperative Virtual Reality for Breast Cancer Surgery Patients: A Feasibility and Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will pilot test and explore the feasibility of a virtual reality simulation of the&#xD;
      operating room environment to reduce preoperative anxiety/distress in breast cancer patients.&#xD;
      Study objectives are to evaluate recruitment and data collection procedures, outcome&#xD;
      measures, participant feedback on the virtual reality operating room intervention, inclusion&#xD;
      of a control intervention and treatment as usual group, and effects of the active&#xD;
      intervention on symptoms of preoperative anxiety/distress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study will employ a single-blind randomized design (1:1:1 randomization; stratified according to surgery type [with vs. without reconstruction] and whether or not neoadjuvant chemotherapy was received; stratification will designate equal proportions of participants with these characteristics across each of the three study groups).</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-reported impressions of the virtual reality operating room simulation</measure>
    <time_frame>Immediately after the intervention</time_frame>
    <description>Patient acceptability questionnaire with open and close-ended items assessing patients' impressions of the intervention</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Anxiety State</condition>
  <arm_group>
    <arm_group_label>Active intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be exposed to a virtual reality simulation of the operating room environment for a minimum of ten minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control intervention group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will explore a non-surgery related virtual reality simulation, pre-programmed to the virtual reality headset for a minimum of ten minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive standard of care with no additional intervention aside from information received at their surgical oncology appointment and optional preoperative education classes (available to all patients).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual reality operating room simulation</intervention_name>
    <description>The virtual reality simulation will begin with the participant sitting on a hospital bed wearing the virtual reality headset and holding the controllers. Participants will be oriented to the environment and provided with an explanation of how to navigate through the simulation (for approximately 2 minutes). Next, participants will explore the virtual operating room for a minimum of 5 minutes, or longer if desired. Following the exploration period, the scripted portion of the simulation will be begin. Here, participants will be taken through the mock anesthetic induction process (the virtual anesthetist will speak to the patient and walk them through the steps and the virtual nurse will assist). The simulation ends after the virtual oxygen mask is placed over the participant's mouth and the screen darkens.</description>
    <arm_group_label>Active intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-surgery-related virtual reality simulation</intervention_name>
    <description>Participants will explore a non-surgery-related virtual reality simulation (e.g., Google Earth simulation) pre-programmed to the virtual reality headset.</description>
    <arm_group_label>Control intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over the age of 18&#xD;
&#xD;
          -  Can speak and read English&#xD;
&#xD;
          -  Has a breast cancer diagnosis&#xD;
&#xD;
          -  Scheduled/being scheduled to undergo breast cancer surgery under general anesthesia at&#xD;
             the Health Sciences Centre (Winnipeg, MB)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who do not meet any inclusion criteria&#xD;
&#xD;
          -  Those who are not competent to provide informed consent (e.g., due to cognitive&#xD;
             impairment)&#xD;
&#xD;
          -  Those who are unable to participate in a virtual reality intervention (e.g., due to&#xD;
             visual/auditory impairment)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jordana Sommer, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ren√©e El-Gabalawy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristin Reynolds, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pamela Hebbard, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Natalie Mota, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alan Mutch, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Mutter, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rakesh Arora, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Manitoba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jessica Maples-Keller, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jordana Sommer, MA</last_name>
    <phone>(204)787-4713</phone>
    <email>sommerj@myumanitoba.ca</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>August 19, 2020</study_first_submitted>
  <study_first_submitted_qc>September 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <last_update_submitted>April 28, 2021</last_update_submitted>
  <last_update_submitted_qc>April 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Jordana Sommer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Preoperative anxiety</keyword>
  <keyword>Breast cancer</keyword>
  <keyword>Virtual reality</keyword>
  <keyword>Feasibility</keyword>
  <keyword>Pilot study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

